, Discovery aid liquid biopsy and immunotherapy research

2020 04 29 22 14 7161 Lab Blood Dropper V2 400

Discovery Life Sciences and outsourced research network provider are joining forces on technology services aiding liquid biopsy and immunotherapy studies.

Through the new offering, Illumina's TruSight Oncology 500 (TSO500) technology for formalin-fixed paraffin-embedded (FFPE) and circulating tumor DNA (ctDNA) services will be made available to users. The TSO500 technology has been incorporated into Discovery's HudsonAlpha Discovery sequencing and bioinformatics laboratory, and is available under one umbrella legal agreement, the companies noted.

Page 1 of 48
Next Page